Role of Thyroid-Stimulating Blocking Antibody in patients who developed hypothyroidism within one year after 131I treatment for Graves' disease

Clinical Endocrinology

Volumn 48, Issue 1, 1998, Pages 17-22

  Yoshida, Katsumi ^a   Aizawa, Yoshihiko ^a   Kaise, Nobuko ^a   Fukazawa, Hiroshi ^a   Kiso, Yoshinori ^a   Sayama, Noriyo ^a   Hori, Hironobu ^a   Nakazato, Naoki ^a   Tani, Jun Ichi ^a   Abe, Keishi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; IODINE 131; LEVOTHYROXINE; THYROID STIMULATING IMMUNOGLOBULIN;

ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID FUNCTION;

ANALYSIS OF VARIANCE; AUTOANTIBODIES; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; IMMUNOGLOBULINS, THYROID-STIMULATING; IODINE RADIOISOTOPES; MIDDLE AGED; RECEPTORS, THYROTROPIN; RETROSPECTIVE STUDIES; THYROTROPIN; TIME FACTORS;

EID: 0031913489     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00330.x     Document Type: Article

References (20)

1. Aizawa, Y., Yoshida, K., Kaise, N., Kaise, K., Fukazawa, H., Kiso, Y., Mori, K., Sayama, N., Kikuchi, K. & Abe, K. (1995) Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease. Clinical Endocrinology, 42, 517-522.
2. Aizawa, Y., Yoshida, K., Kaise, N., Kaise, K., Fukazawa, H., Kiso, Y., Sayama, N., Hori, H. & Abe, K. (1997) The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism, and prognosis. Clinical Endocrinology, 46, 1-5.
3. Atkinson, S., McGregor, A.M., Kendall-Taylor, P., Peterson, M.M. & Smith, B.R. (1982) Effect of radioiodine on stimulatory activity of Graves' immunoglobulins. Clinical Endocrinology, 16, 537-543.
4. Bech, K., Bliddal, H., Sierbaek-Nielsen, K. & Friis, T. (1982) Production of non-stimulatory immunoglobulins that inhibit TSH binding in Graves' disease after radioiodine administration. Clinical Endocrinology, 17, 395-402.
5. Dorfmann, S.G., Young, R.L. & Carfetta, R.F. (1977) Transient hypothyroidism. Archives of Internal Medicine, 137, 256-257.
6. Endo, K., Kasagi, K., Konishi, J., Ikekubo, K., Okuno, T., Takeda, Y., Mori, T. & Torizuka, K. (1978) Detection and properties of TSH binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism, 46, 734-739.
7. Farrar, J.J. & Toft, A.D. (1991) Iodine-131 treatment of hyperthyroidism: current issues. Clinical Endocrinology, 35, 207-212.
8. 131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease. Journal of Clinical Endocrinology and Metabolism, 62, 773-777.
9. Graham, G.D. & Burman, K.D. (1986) Radioiodine treatment of Graves' disease. An assessment of its potential risks. Annals of Internal Medicine, 105, 900-905.
10. Hashim, F.A., Creagh, F.M., Hawrani, A.E.L., Parkes, A.B., Buckland, P.R. & Smith, B.R. (1986) Characterization of TSH antagonist activity in the serum of patients with thyroid disease. Clinical Endocrinology, 25, 275-281.
11. 131I) therapy for hyperthyroid Graves' disease. Endocrinologia Japonica, 38, 429-433.
12. Kasagi, K., Konishi, J., Iida, Y., Arai, K., Endo, K. & Torizuka, K. (1987) A sensitive and practical assay for thyroid-stimulating antibodies using FRTL-5 thyroid cells. Acta Endocrinologica (Copenh), 155, 30-36.
13. Kendall-Taylor, P., Keir, MJ. & Ross, W.M. (1984) Ablative radioiodine therapy for hyperthyroidism: long-term follow up study. British Medical Journal, 289, 361-363.
14. Konishi, J., Iida, Y., Kasagi, K., Misaki, T., Nakashima, T., Endo, K., Mori, T., Shinpo, S., Nohara, Y., Matsuura, N. & Torizuka, K. (1985) Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins. Annals of Internal Medicine, 103, 26-31.
15. McGregor, A.M., Petersen, M.M., Capiferri, R., Evered, D.C., Smith, B.R. & Hall, R. (1979) Effects of radioiodine on thyrotropin binding inhibiting immunoglobulins in Graves' disease. Clinical Endocrinology, 11, 437-444.
16. Michelangeli, V.P., Poon, C., Topliss, D.J. & Colman, P.G. (1995) Specific effects of radioiodine treatment on TSAb and TBAb levels in patients with Graves' disease. Thyroid, 5, 171-176.
17. Sawers, J.S., Toft, A.D., Irvine, W.J., Brown, N.S. & Seth, J. (1980) Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism, 50, 226-229.
18. Shewring, G. & Smith, B.R. (1982) An improved radioreceptor assay for TSH receptor antibodies. Clinical Endocrinology, 17, 409-417.
19. Takasu, N., Yamada, T., Takasu, M., Komiya, I., Nagasawa, Y., Asawa, T., Shinoda, T., Aizawa, T. & Koizumi, Y. (1992) Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. New England Journal of Medicine, 326, 513-518.
20. Yoshida, K., Aizawa, Y., Raise, N., Fukazawa, H., Kiso, Y., Sayama, N., Mori, K., Hori, H. & Abe, K. (1996) Relationship between thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine for Graves' disease: retrospective clinical survey. Journal of Endocrinological Investigation, 19, 682-686.